SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-18-045654
Filing Date
2018-02-14
Accepted
2018-02-14 16:19:37
Documents
2
Group Members
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d527041dsc13g.htm SC 13G 60846
2 EX-99.1 d527041dex991.htm EX-99.1 3673
  Complete submission text file 0001193125-18-045654.txt   66094
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Subject) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90283 | Film No.: 18612548
SIC: 2834 Pharmaceutical Preparations